rifapentine-based regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rifapentine-based regimen, covering 2023-12-11 to 2023-12-11. Get the full timeline:
Most recent: Clinical Trial Update: Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T) [Phase 2, Phase 3]